SELEX is a powerful method for the identification of small oligonucleotides which bind with high affinity and specificity to target proteins. Such DNAs/RNAs are a new class of potential chemotherapeutics which could block the enzymatic activity of pathologically relevant proteins. We have conducted a detailed biochemical study of the interaction of HIV-1 reverse transcriptase (RT) with a SELEX derived pseudoknot RNA aptamer. Electron paramagnetic resonance spectroscopy of site-directed spin-labeled RT mutants revealed that this aptamer was selected for binding to the "closed" conformation of the enzyme. Kinetic analysis showed that the RNA inhibitor bound to HIV RT in a two step process, with similar association rates to those described for model DNA/DNA and DNA/RNA substrates. However, the dissociation of the pseudoknot RNA from RT was dramatically slower than observed for model substrates. Equilibrium binding studies revealed an extraordinarily low K d , of about 25 pM, for the enzyme/aptamer interaction, presumably a consequence of the slow off-rates.
Introduction

HIV
reverse transcriptase (RT), a key enzyme of the retroviral life cycle, catalyses the conversion of the single stranded genomic viral RNA into double stranded proviral DNA, which in turn is integrated into the host genome. The enzyme consists of an asymmetric (for a review see 4). Tuerk and Gold (5) have used SELEX to identify RNA aptamers against the HIV-1 RT. The analysis of the isolated aptamers revealed a consensus sequence that resulted in the formation of an RNA pseudoknot (6) . The interactions between SELEX RNA pseudoknots and HIV-1 RT have been analyzed in some detail using biochemical studies and chemical modification (7, 8) .
Pseudoknots are defined as loop regions base pairing with complementary sequences, outside the loop, in the same RNA molecule (9, 10) . The pseudoknot fold is a widespread structural motif found in all kinds of RNA, including coding and noncoding regions of cellular mRNAs, viral RNAs, ribosomal RNAs, and snRNAs. Although not all of the functions of this RNA secondary structure motif are fully understood, pseudoknots play an important role in ribosomal frameshifting, in transcriptional read-through, as internal ribosomal entry sites, as translational enhancers, and are key components of ribozymes (11) and cis-acting elements important for the initiation of viral replication (for a review see 12) . Several NMR studies and one high resolution X-ray study of pseudoknots have been reported (13) (14) (15) (16) (17) (18) (19) .
The X-ray structure of HIV-1 RT complexed with an RNA pseudoknot inhibitor has been solved recently (see Figure 1; 20) . This is the first example of an X-ray structure of such an pseudoknot aptamer bound to its target protein. The RNA ligand binding surface lies within the nucleic acid cleft of the enzyme, between the polymerase and RNaseH active sites, and partially overlapping the binding surface of duplex DNA substrates. The pseudoknot is kinked by 60° from the co-axial stacking of stems 1 and 2, thus optimizing the extensive contacts between the RNA inhibitor and both subunits of the heterodimeric enzyme. The protein/RNA interaction stabilizes the "closed" conformation of the enzyme, where the fingers and thumb domains of the large subunit are in close contact. Further, we suggested that the SELEX procedure appears to have identified an RNA molecule whose uncomplexed solution structure by guest on October 29, 2017 http://www.jbc.org/ Downloaded from is very similar to its structure when bound to RT and which binds to the unliganded conformation of RT.
Here we present the first detailed biochemical study of the this enzyme/inhibitor interaction.
Using electron paramagnetic resonance (EPR) spectroscopy of site-directed spin-labeled RT mutants, we show that the relative positions of the fingers and thumb domains of the large subunit are virtually indistinguishable whether or not RNA is bound. This proves, for the first time, that RT in solution can adopt the closed conformation seen in the X-ray structure by Rodgers et al. (21) and might be an important feature of selecting for tight binding ligands. An analysis of the binding equilibrium of the protein/inhibitor complex revealed astonishingly tight binding, with a K d in the low picomolar range, about 2-3 orders of magnitude lower than the K d of about 5 nM reported earlier by Tuerk et al. (6) . To our knowledge, this is the first report of a SELEX derived RNA ligand showing such a tight binding for a known nucleic acid binding target protein.
Experimental procedures
Mutagenesis of reverse transcriptase
To label RT with either spin labels or fluorophors in a site directed manner, the naturally occurring cysteines had to be replaced by serines and cysteines had to be introduced at the desired positions. In a first step, the mutant RT p66 C38S,C280S /p51 C280S was generated. The cysteine at position 38 in the small subunit is not solvent accessible and consequently does not interfere with site-directed labeling (Kensch, unpublished data) . In a second step cysteines at certain positions were introduced as given in the text.
Mutant RT was prepared by site directed mutagenesis using PCR (22) . The mutations were introduced into the plasmids pRT1 66 (23) and p6HRT51 (24) . The generated plasmids were transformed into Escherichia coli (E. coli) M15/pDMI.1 (25) resulting in expression systems for mutated p66 and mutated his-tagged p51.
Protein Purification
Recombinant heterodimeric wild type HIV-1, HIV-2 and EIAV RT were expressed in E. coli and purified as described before (23, 26, 27) . Enzyme concentrations were routinely determined using an extinction coefficient at 280 nm of 260450 M Mutant RTs were purified according to a protocol described previously (28) . Cohomogenization of E. coli cells expressing p66 or p51, respectively, led to reconstruction of heterodimeric p66/p51 RT. Analysis of the mutant proteins by a standard RT assay (see below) showed indistinguishable polymerase activity as compared to the wild type enzyme.
Labeling of RT mutants
Spin labeling of the introduced cysteine residues at position 24 and 287 in p66 was achieved by the following procedure. In order to reduce any disulfide bonds, 2 µl 1 M DTT was added to 200 µl of a 44 µM solution of mutant RT (p66 W24C, C38S, C280S, K287C /p51 C280S ) in buffer A.
After 30 min at 4° C a 2-fold excess of 18/36mer DNA/DNA p/t was added to the solution.
The resulting RT-p/t complex was separated from excess DTT using a Sephadex G25 gel filtration column (Pharmacia). The eluted complex was collected in a tube containing 2 µl of 100 µM (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methane-thiosulfonate (MTSSL; Toronto Research Chemicals, Inc.) in DMSO. After 16 h at 4° C, excess spin label and bound p/t were removed by purifying the enzyme over a Ni
2+
-nitrilotriacetic acid-Sepharose column (Qiagen). The bound protein was washed extensively with a buffer containing 1 M NaCl and eluted with 0.3 M imidazole. Subsequently the protein solution was concentrated and buffer was changed (50 mM Tris-HCl, pH 8.0, 25 mM NaCl, 6 mM MgCl 2 , 10% glycerol) using centrifugal filters (Millipore). Finally samples were shock frozen in liquid nitrogen and stored at -80° C. The labeled cysteine/RT ratio estimated from double integration of the EPR spectra and absorption measurements of protein (280 nm) was found to be > 90%. Analysis of the spin labeled protein by a standard RT assay (see below) show polymerase activity which was indistinguishable from that of wild type enzyme.
The labeling of the HIV-1 RT mutant (p66 
RNA Preparation
The 33 nt pseudoknot RNA (sequence: 5'-GGGAGAUUCCGUUUUCAGUCGGGAAAAACUGAA) was prepared in a standard 10 ml T7 reaction mixture for in vitro transcription and purified by gel electrophoresis as described previously (20, 29) . The RNA was refolded at a concentration of 200 -300 µM at 65° C for 5 min followed by slow cooling to room temperature in 20 mM cacodylate buffer pH 6.5, 25
mM NaCl and 5 mM MgCl 2 . 5'-end-labelling of the RNA with T4 polynucleotide kinase (New England Biolabs) was performed as described previously (30) . Dephosphorylation of the in vitro transcribed RNA prior to endlabeling was carried out according to standard procedures (31) . The fluorescent-labeled 5'-HEX-(hexachlorofluorescein)-pseudoknot RNA was synthesized and HPLC-purified as previously described (32 
Filter Binding Assay
Protein and 5'-32 P-labeled RNA were mixed in standard buffer and incubated at 25° C for 10
min. An aliquot of this mixture was filtered under suction through a prewet (standard buffer)
nitro-cellulose filter (Schleicher & Schuell BA85) and rinsed with 4 ml of standard buffer.
Radioactivity retained on the filters was measured by scintillation counting.
Fluorescence Equilibrium Measurements of RT/RNA Binding
The affinity of the different RTs for the pseudoknot RNA was measured both by displacing a fluorescently labeled 18/36-mer DNA/DNA p/t bound to RT and by titrating increasing amounts of RT with 5'-HEX-labeled RNA.
The fluorescently labeled DNA-primer was synthesized by coupling the phosphoroamidite dye 6-FAM, a fluorescein derivative, directly to the 5'-end of the oligodeoxynucleotide during DNA synthesis according to the recommendation of the manufacturer (Applied Biosystems).
The titrations were performed using an SLM AB2 spectrofluorometer. To monitor the fluorescence change upon displacing the labeled p/t from RT, the samples were excited at 492 nm and the emission intensity was measured at 516 nm. These competitive titrations were evaluated using the program Scientist (MicroMath), which allows the user to define the system under investigation as a series of parallel equations defining (in this case) each discrete equilibrium, the relationship between the total and free concentrations of the components, and the way in which the observable signal is generated. The K d of the 18/36mer DNA/DNA p/t was determined independently (30, 35) and kept constant during the fit procedure (primer sequence: 5´-TCCCTGTTCGGGCGCCAC-3´; template sequence 5´-
TGTGGAAAATCTCATGCAGTGGCGCCCGAACAGGGA-3´).
To monitor the fluorescence change upon binding of RT to the 5'-HEX-labeled pseudoknot RNA, the samples were excited at 538 nm and the emission intensity was measured at 556 nm. Data were fitted to a quadratic equation analogous to the one given by Müller et al. (36) using the program Grafit (Erithacus Software). Values for the dissociation constant (K d ), the amplitude of the fluorescence change and the RNA concentration were allowed to vary during the fit procedure.
Rapid kinetics of RT/RNA interaction
Experiments on the kinetics of the association of HIV-1 RT with the pseudoknot RNA were performed using a stopped flow apparatus (High Tech Scientific, Salisbury, England). 25 nM of a Alexa 488 -labeled HIV-1 RT (final concentration) was rapidly mixed with increasing 5'-HEX-labeled pseudoknot RNA concentrations (50 -300 nM). Collection and analysis of the data was done as described previously (27, 30) . Excitation of the Alexa 488 -labeled protein was at 435 nm and detection of the donor quenching due to fluorescence resonance energy transfer to the HEX-fluorophor was through a bandpass filter (520 nm). Data were fitted using a double exponential equation. The rate of the first phase (k +1 ) is dependent on the concentration of RT and corresponds to the formation of the collision complex. The rate k +2 of the second phase is largely concentration independent and arises from a conformational change of the RT-RNA complex after formation of the collision complex.
EPR Measurements
Continuous wave EPR experiments were performed using home made X-band EPR spectrometers equipped with a dielectric resonator (Bruker) or with an H 103 cavity (AEG). The interaction due to the motion of the spin labels allows an estimation of the inter-residue distances at room temperature (41) . Exchange interaction was found to contribute significantly to the line broadening for distances of less than 10 Å, since partial overlap of the nitrogen piorbitals of the two interacting nitroxides is required (42, 43) .
Results
Affinity of HIV-1 RT for the pseudoknot RNA by equilibrium binding
Binding measurements to determine the K d of the RT/RNA complex were performed using three different approaches. Figure 2A shows a displacement titration using a fluorescently labeled DNA/DNA p/t, for which the affinity has previously been determined (35) . 
Kinetics of RT/RNA association
Stopped flow experiments were performed to analyze the association of RT with RNA.
Binding of RT to the 5'-HEX-labeled pseudoknot RNA results in quenching of the fluorescence signal of about 6 % (see Figure 2B ). This rather small signal change was, however, not sufficient to obtain reasonable data in stopped flow experiments. We therefore 
Analysis of the RT/RNA dissociation
Attempts to measure the dissociation rate of the protein/RNA complex using stopped flow did not result in an appreciable signal change over the maximal useful time range of the instrument, indicating that this process might be too slow to be measured by this approach.
Thus, the filter binding assay was applied to determine the dissociation rate of the complex. . Essentially the same rate constant was determined using the 5'-HEX-labeled pseudoknot in a fluorescence spectrofluorimeter (data not shown).
Binding of RT to the pseudoknot RNA by kinetic measurements
The results outlined above, show that the binding of the pseudoknot RNA to HIV-1 RT can be best described as a two step process. , respectively. The latter was indirectly derived from the y-axis intercept of a linear fit of RNA concentration versus observed pseudo-firstorder rate and therefore is subject to a rather large error (see Figure 3B ). Efforts to observe k -1 directly by performing double mixing stopped flow experiments did not yield interpretable data (data not shown). A K d of about 0.8 pM can be calculated from these rate constants, about 30 times lower than determined using equilibrium measurements.
Affinity of HIV-2 and EIAV RT for the pseudoknot
To investigate the specificity of the interaction of the pseudoknot with HIV-1 RT binding studies were carried out with the closely related RTs of HIV-2 and EIAV (equine infectious anemia virus). 
Effect of the RNA on polymerase activity of different RTs
To further illustrate the exceptional specificity of the pseudoknot RNA for the HIV-1 enzyme we performed standard RT assays using poly(rA)/oligo(dT) as substrate. The reactions were started with preincubated RT/RNA complexes. Figure 6 
EPR measurements
Site directed spin labeling has emerged as a powerful technique for exploring the structure and dynamics of both soluble and membrane proteins (for a recent review see 46) . We have applied this method to determine in solution the relative positions of the fingers and thumb domains of the p66 subunit of RT, both as an unliganded apo-enzyme and in the presence of bound nucleic acids, and have compared these data with data obtained from X-ray analysis (for a review see 1). RT was mutagenised to introduce two unique cysteines in the p66 subunit. Subsequent reaction with a thiol specific nitroxide resulted in an RT variant carrying two spin labels, one at the tip of the fingers and the second in the thumb domain (amino acids 24 and 287 respectively, see Figure 1 ). EPR spectroscopy was used to determine the distance between these spin labels.
The EPR spectra of spin-labeled RT liganded to either a DNA/DNA p/t (18/36-mer) or the pseudoknot RNA were measured at 170 K in frozen solution to exclude dynamic effects and motional averaging of the dipolar broadening. Room temperature measurements (T = 293 K)
were performed to characterize the mobility of the spin label side chains and to study spinspin interaction at a more physiological temperature. The EPR spectra were normalized to represent the same number of spins. The results, shown in Figure with spectra of MTSSL bound to the E-F cytoplasmic loop of bacteriorhodopsin (48) . The lack of any additional spectral component of considerable amplitude reveals that the dynamics of both nitroxide side chains must be very similar. In the RNA-bound species of RT, the apparent hyperfine splitting is only slightly increased, indicating only minor changes in the tertiary interaction of the nitroxides compared to the DNA bound structure. However, the line width is substantially increased, which must be due to spin-spin interaction. The spectrum of the RNA-bound RT can be fit reasonably well by the convolution of a Lorentzian function with the spectrum of the DNA bound species. The non-broadened contribution to the spectrum is most probably due to a small fraction of singly labeled species, which amounts to less than 10%. The broadening appears to be homogeneous across the spectrum, and the line width at half height, ∆H, of the Lorentzian provides a quantitative measure of the spin-spin interaction (41) . The best fit is obtained with ∆H = 6 G, which yields an inter-spin distance of 12.5 Å according to the empirical calibration given by Mchaourab et al. (41) . Due to the high flexibility of the nitroxides and since we do not distinguish between exchange and dipolar interaction, this value has to be regarded as an estimate of the average inter-spin distance.
Additionally, as the line width depends on r -6 , the average is weighted in favour of molecules with smaller inter-spin distances. With this in mind, the estimated distance value agrees well with that determined from the low temperature experiment.
At room temperature, the spectrum of the substrate free RT is nearly indistinguishable from that of the RNA bound species. Since the spectral shape of this mutant is determined by the spin-spin interaction, this result is strong evidence that the finger-thumb distance of the main fraction of the free RT is identical to that of the RNA bound structure.
Discussion
Comparing the X-ray structure of the pseudoknot RNA / RT complex (20) Typically, RNA aptamers selected for tight binding to protein targets show binding constants in the low nM -µM range (52) . Occasionally tighter binding with K d s of 100 -500 pM is reported. However, to our knowledge an RNA aptamer with a binding constant of ≤ 25 pM has not been described so far. This aptamer shows at least a 100 fold tighter binding than the natural substrate, exceptional specificity and a broad working range concerning buffer conditions, making it an encouraging drug candidate for the treatment of HIV infections.
Experiments are in progress to evaluate the inhibitory potential of this pseudoknot RNA in cell tissue culture. 
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